PLTR vs STRO
Palantir Technologies Inc. Class A Common Stock (PLTR) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported PLTR revenue for 2025-12-31 was $4.48B. Net income was $1.63B. Revenue was up 56.2% from 2024-12-31 to 2025-12-31. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
PLTR currently screens at market cap $317.08B and trailing P/E 584.2. STRO currently screens at market cap $470.8M.
Not investment advice. Open the PLTR and STRO stock pages for the full models.
Not investment advice.